Enlivex Therapeutics Stock Price History

ENLV Stock  USD 1.09  0.03  2.68%   
Below is the normalized historical share price chart for Enlivex Therapeutics extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enlivex Therapeutics stands at 1.09, as last reported on the 21st of March, with the highest price reaching 1.09 and the lowest price hitting 1.09 during the day.
IPO Date
12th of December 1995
200 Day MA
1.2786
50 Day MA
1.1136
Beta
1.108
 
Yuan Drop
 
Covid
If you're considering investing in Enlivex Stock, it is important to understand the factors that can impact its price. Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0272, which denotes the company had a -0.0272 % return per unit of risk over the last 3 months. Enlivex Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enlivex Therapeutics' Standard Deviation of 4.31, variance of 18.62, and Mean Deviation of 2.78 to check the risk estimate we provide.
  
At this time, Enlivex Therapeutics' Common Stock is fairly stable compared to the past year. Preferred Stock Total Equity is likely to climb to about 10.2 M in 2025, whereas Treasury Stock is likely to drop (959.2 K) in 2025. . Price To Sales Ratio is likely to drop to 39.01 in 2025. Price Earnings Ratio is likely to drop to -1.63 in 2025. Enlivex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0272

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsENLV

Estimated Market Risk

 4.46
  actual daily
39
61% of assets are more volatile

Expected Return

 -0.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Enlivex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enlivex Therapeutics by adding Enlivex Therapeutics to a well-diversified portfolio.
Price Book
0.9263
Book Value
1.209
Enterprise Value
888.3 K
Enterprise Value Ebitda
(1.49)
Shares Float
16.1 M

Enlivex Therapeutics Stock Price History Chart

There are several ways to analyze Enlivex Stock price data. The simplest method is using a basic Enlivex candlestick price chart, which shows Enlivex Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 26, 20241.25
Lowest PriceFebruary 25, 20250.98

Enlivex Therapeutics March 21, 2025 Stock Price Synopsis

Various analyses of Enlivex Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enlivex Stock. It can be used to describe the percentage change in the price of Enlivex Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enlivex Stock.
Enlivex Therapeutics Price Rate Of Daily Change 0.97 
Enlivex Therapeutics Price Action Indicator(0.02)

Enlivex Therapeutics March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Enlivex Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Enlivex Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Enlivex Stock and then apply it to test your longer-term investment strategies against Enlivex.

Enlivex Stock Price History Data

The price series of Enlivex Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.28 with a coefficient of variation of 6.51. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.14. The median price for the last 90 days is 1.15. The company completed 1:8 stock split on 6th of March 2019. Enlivex Therapeutics completed dividends distribution on 2019-03-06.
OpenHighLowCloseVolume
03/21/2025
 1.12  1.09  1.09  1.09 
03/21/2025
 1.12  1.18  1.08  1.09 
03/19/2025 1.15  1.18  1.08  1.12  95,944 
03/18/2025 1.14  1.24  1.12  1.14  151,563 
03/17/2025 1.22  1.22  1.10  1.15  177,406 
03/14/2025 1.14  1.29  1.12  1.22  236,788 
03/13/2025 1.21  1.23  1.07  1.09  121,837 
03/12/2025 1.18  1.24  1.16  1.20  78,684 
03/11/2025 1.15  1.20  1.15  1.16  117,258 
03/10/2025 1.19  1.23  1.02  1.16  428,222 
03/07/2025 1.17  1.29  1.15  1.19  470,824 
03/06/2025 1.10  1.17  1.04  1.15  114,419 
03/05/2025 1.05  1.16  1.05  1.13  120,313 
03/04/2025 1.05  1.17  1.01  1.08  295,632 
03/03/2025 1.03  1.12  0.94  1.02  2,024,554 
02/28/2025 1.04  1.24  1.01  1.20  432,004 
02/27/2025 1.05  1.05  1.00  1.03  87,534 
02/26/2025 1.04  1.09  0.98  1.00  69,283 
02/25/2025 1.01  1.01  0.97  0.98  60,673 
02/24/2025 1.02  1.02  0.97  0.99  35,145 
02/21/2025 1.01  1.03  0.98  1.00  42,697 
02/20/2025 1.05  1.06  1.01  1.02  34,322 
02/19/2025 1.06  1.09  1.00  1.05  68,433 
02/18/2025 1.07  1.08  1.01  1.05  62,224 
02/14/2025 1.08  1.10  1.02  1.05  75,680 
02/13/2025 1.04  1.06  1.00  1.04  38,981 
02/12/2025 1.02  1.07  1.01  1.05  48,107 
02/11/2025 1.09  1.09  1.03  1.06  16,560 
02/10/2025 1.08  1.14  1.07  1.09  68,847 
02/07/2025 1.01  1.12  1.00  1.10  30,530 
02/06/2025 1.09  1.12  1.00  1.03  50,244 
02/05/2025 1.11  1.14  1.07  1.10  53,853 
02/04/2025 1.11  1.11  1.05  1.08  45,211 
02/03/2025 1.06  1.09  1.00  1.08  48,350 
01/31/2025 1.08  1.11  1.05  1.10  24,662 
01/30/2025 1.10  1.12  1.06  1.11  47,891 
01/29/2025 1.11  1.12  1.05  1.11  44,203 
01/28/2025 1.14  1.15  1.08  1.13  35,968 
01/27/2025 1.14  1.18  1.06  1.15  129,095 
01/24/2025 1.18  1.19  1.16  1.18  49,290 
01/23/2025 1.20  1.21  1.14  1.19  47,441 
01/22/2025 1.20  1.20  1.17  1.19  30,215 
01/21/2025 1.17  1.21  1.15  1.19  91,756 
01/17/2025 1.16  1.17  1.12  1.13  45,575 
01/16/2025 1.15  1.16  1.13  1.15  36,812 
01/15/2025 1.14  1.15  1.13  1.15  93,467 
01/14/2025 1.16  1.19  1.10  1.14  86,085 
01/13/2025 1.15  1.17  1.13  1.15  60,970 
01/10/2025 1.18  1.21  1.12  1.15  78,562 
01/08/2025 1.23  1.23  1.15  1.18  108,432 
01/07/2025 1.25  1.26  1.22  1.25  122,649 
01/06/2025 1.23  1.25  1.19  1.23  111,875 
01/03/2025 1.25  1.27  1.22  1.25  132,634 
01/02/2025 1.20  1.25  1.19  1.24  94,288 
12/31/2024 1.12  1.17  1.12  1.17  174,008 
12/30/2024 1.15  1.20  1.13  1.15  129,010 
12/27/2024 1.24  1.25  1.14  1.19  219,633 
12/26/2024 1.23  1.25  1.22  1.25  102,317 
12/24/2024 1.23  1.25  1.21  1.23  44,753 
12/23/2024 1.20  1.26  1.20  1.24  99,367 
12/20/2024 1.19  1.25  1.16  1.24  141,570 

About Enlivex Therapeutics Stock history

Enlivex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enlivex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enlivex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enlivex Therapeutics stock prices may prove useful in developing a viable investing in Enlivex Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding21.4 M22.4 M
Net Loss-28 M-26.6 M

Enlivex Therapeutics Quarterly Net Working Capital

24.32 Million

Enlivex Therapeutics Stock Technical Analysis

Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Enlivex Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Enlivex Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Enlivex Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Enlivex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Enlivex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enlivex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Enlivex Stock Analysis

When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.